Clinical Trial Update: Gene Therapy Using Anti-CEA Cells to Treat Metastatic Cancer [Phase 1]

View source ↗

Summary

This Phase 1 trial evaluating anti-CEA cell therapy for metastatic cancer was terminated. The study was sponsored by the National Cancer Institute.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Anti-CEA cell therapy

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Metastatic Cancer | Phase 1 | Status: TERMINATED